Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001790340-24-000024
Filing Date
2024-03-01
Accepted
2024-03-01 08:05:34
Documents
119
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imrx-20231231.htm   iXBRL 10-K 1855866
2 EX-10.4 mallorymorales-imrxxemploy.htm EX-10.4 161011
3 EX-10.6 mallorymorales-imrxxletter.htm EX-10.6 6797
4 EX-10.8 brakewoodharold-employment.htm EX-10.8 164383
5 EX-10.15 imrx-amendednonxemployeedi.htm EX-10.15 37096
6 EX-23.1 rsmconsent.htm EX-23.1 2128
7 EX-31.1 imrx-20231231x10kxexx311.htm EX-31.1 10241
8 EX-31.2 imrx-20231231x10kxexx312.htm EX-31.2 10220
9 EX-32.1 imrx-20231231x10kxexx321.htm EX-32.1 5120
10 EX-32.2 imrx-20231231x10kxexx322.htm EX-32.2 5416
11 EX-97.1 imrx-policyforrecoveryofer.htm EX-97.1 41068
17 image_01.jpg GRAPHIC 7898
18 image_11.jpg GRAPHIC 1582
19 image_21.jpg GRAPHIC 7772
20 image_22.jpg GRAPHIC 21373
21 image_2b.jpg GRAPHIC 153
22 image_31.jpg GRAPHIC 22970
23 image_4a.jpg GRAPHIC 10450
24 image_8.jpg GRAPHIC 10627
25 imrx-20231231_g1.jpg GRAPHIC 31912
26 imrx-20231231_g10.jpg GRAPHIC 279068
27 imrx-20231231_g11.jpg GRAPHIC 51737
28 imrx-20231231_g12.jpg GRAPHIC 220198
29 imrx-20231231_g13.jpg GRAPHIC 259590
30 imrx-20231231_g14.jpg GRAPHIC 268253
31 imrx-20231231_g15.jpg GRAPHIC 271589
32 imrx-20231231_g16.jpg GRAPHIC 281096
33 imrx-20231231_g17.jpg GRAPHIC 938155
34 imrx-20231231_g18.jpg GRAPHIC 505507
35 imrx-20231231_g19.jpg GRAPHIC 157520
36 imrx-20231231_g2.jpg GRAPHIC 152890
37 imrx-20231231_g20.jpg GRAPHIC 219358
38 imrx-20231231_g21.jpg GRAPHIC 68305
39 imrx-20231231_g22.jpg GRAPHIC 69296
40 imrx-20231231_g23.jpg GRAPHIC 99330
41 imrx-20231231_g24.jpg GRAPHIC 221462
42 imrx-20231231_g25.jpg GRAPHIC 44457
43 imrx-20231231_g26.jpg GRAPHIC 30834
44 imrx-20231231_g27.jpg GRAPHIC 31068
45 imrx-20231231_g28.jpg GRAPHIC 31966
46 imrx-20231231_g3.jpg GRAPHIC 129820
47 imrx-20231231_g4.jpg GRAPHIC 31815
48 imrx-20231231_g5.jpg GRAPHIC 55604
49 imrx-20231231_g6.jpg GRAPHIC 44119
50 imrx-20231231_g7.jpg GRAPHIC 132128
51 imrx-20231231_g8.jpg GRAPHIC 92821
52 imrx-20231231_g9.jpg GRAPHIC 90167
  Complete submission text file 0001790340-24-000024.txt   20073538

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20231231.xsd EX-101.SCH 41574
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imrx-20231231_cal.xml EX-101.CAL 72173
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imrx-20231231_def.xml EX-101.DEF 226042
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20231231_lab.xml EX-101.LAB 660390
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20231231_pre.xml EX-101.PRE 434881
120 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20231231_htm.xml XML 798827
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40675 | Film No.: 24707039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)